Dudediligence.

Definium Therapeutics, Inc

DFTXNASDAQ · Medicinal Chemicals & Botanical Products
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$13.7MSep ’24−$34.7MDec ’24−$23.3MMar ’25−$42.7MJun ’25−$67.3MSep ’25−$50.4MDec ’25−$77.1MMar ’26−$159.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$93.9M−$66.3M−$93.9M−$103.9M−$166.3M
Net income−$93.0M−$56.8M−$95.7M−$108.7M−$183.8M
Operating cash flow−$45.8M−$50.1M−$64.4M−$79.1M−$131.6M
Cash$133.5M$142.1M$99.7M$273.7M$257.8M
Debtnone on filenone on file$14.1M$21.9M$40.6M
Shares outstanding28.1M38.0M41.1M75.1M98.8M